Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers

Figure 5

Rate of positive results for p53, MMP-7, Hsp70, and the panel in patients with NMSC according to the clinicopathological variables of tumors.